Euroopa Liit -
eesti -
EMA (European Medicines Agency)
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - muud antineoplastilised ained - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
Eesti -
eesti -
Ravimiamet
lysa vaginaalkõvakapsel
proge farm s.r.l. - laktobatsillid - vaginaalkõvakapsel - 100000000cfu 6tk; 100000000cfu 3tk
Eesti -
eesti -
Ravimiamet
lysa vaginaalpehmekapsel
proge farm s.r.l. - laktobatsillid - vaginaalpehmekapsel - 100000000cfu 6tk; 100000000cfu 3tk